IQVIA (NYSE:IQV) Releases FY 2025 Earnings Guidance

IQVIA (NYSE:IQV) updated its FY 2025 earnings guidance on Thursday. The company provided EPS guidance of 11.700-12.100 for the period, compared to the consensus EPS estimate of 11.880. The company issued revenue guidance of $15.7 billion-$16.1 billion, compared to the consensus revenue estimate of $16.0 billion.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently issued reports on the company. JPMorgan Chase & Co. dropped their target price on IQVIA from $279.00 to $240.00 and set an “overweight” rating for the company in a report on Tuesday, November 5th. The Goldman Sachs Group cut their price objective on IQVIA from $280.00 to $250.00 and set a “buy” rating for the company in a report on Friday, November 1st. Robert W. Baird lowered their target price on shares of IQVIA from $212.00 to $210.00 and set a “neutral” rating on the stock in a report on Tuesday, January 21st. Deutsche Bank Aktiengesellschaft cut their price target on shares of IQVIA from $270.00 to $265.00 and set a “buy” rating for the company in a report on Friday, November 1st. Finally, Barclays dropped their price objective on shares of IQVIA from $255.00 to $235.00 and set an “overweight” rating for the company in a report on Monday. Five analysts have rated the stock with a hold rating, sixteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $254.53.

IQVIA Trading Up 2.5 %

IQVIA stock opened at $205.12 on Thursday. The company has a debt-to-equity ratio of 1.76, a quick ratio of 0.81 and a current ratio of 0.81. The stock has a 50-day simple moving average of $200.29 and a 200 day simple moving average of $219.97. The stock has a market capitalization of $37.23 billion, a P/E ratio of 26.92, a PEG ratio of 2.15 and a beta of 1.48. IQVIA has a 52 week low of $187.62 and a 52 week high of $261.73.

IQVIA (NYSE:IQV) last issued its quarterly earnings data on Thursday, February 6th. The medical research company reported $2.90 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.11 by ($0.21). IQVIA had a return on equity of 28.17% and a net margin of 9.17%. Analysts expect that IQVIA will post 10.18 earnings per share for the current year.

About IQVIA

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.